Insider Trading Activity Intersect ENT, Inc. (NASDAQ:XENT) – CFO Sold 12,833 shares of Stock

ME Staff
-
0

Insider Trading Activity For Intersect ENT, Inc. (NASDAQ:XENT)

Jeryl L Hilleman , CFO of Intersect ENT, Inc. (NASDAQ:XENT) reportedly Sold 12,833 shares of the company’s stock at an average price of 29 for a total transaction amount of $372,157.00 SEC Form

Insider Trading History For Intersect ENT, Inc. (NASDAQ:XENT)

  • On 9/11/2014 Cynthia L Lucchese, Director, bought 5,000 with an average share price of $17.11 per share and the total transaction amounting to $85,550.00.View SEC Filing
  • On 1/26/2015 Robert H Binney Jr, VP, sold 6,300 with an average share price of $21.18 per share and the total transaction amounting to $133,434.00.View SEC Filing
  • On 2/2/2015 James Stambaugh, VP, sold 8,343 with an average share price of $20.98 per share and the total transaction amounting to $175,036.14.View SEC Filing
  • On 2/12/2015 Amy Wolbeck, VP, sold 8,000 with an average share price of $22.12 per share and the total transaction amounting to $176,960.00.View SEC Filing
  • On 2/17/2015 Lisa D Earnhardt, Insider, sold 19,318 with an average share price of $22.69 per share and the total transaction amounting to $438,325.42.View SEC Filing
  • On 3/9/2015 James Stambaugh, VP, sold 8,343 with an average share price of $23.02 per share and the total transaction amounting to $192,055.86.View SEC Filing
  • On 3/11/2015 Amy Wolbeck, VP, sold 8,000 with an average share price of $23.06 per share and the total transaction amounting to $184,480.00.View SEC Filing

    • Analyst Ratings For Intersect ENT, Inc. (NASDAQ:XENT)
    These are 2 Hold Ratings, 7 Buy Ratings .
    The current consensus rating for Intersect ENT, Inc. (NASDAQ:XENT) is Buy (Score: 2.78) with a consensus target price of $23.13 , a potential (24.30% downside)

    Analyst Ratings History For Intersect ENT, Inc. (NASDAQ:XENT)

    • On 10/2/2015 Sterne Agee CRT Reiterated Rating Buy with a price target of $37.00
    • On 12/18/2015 Bank of America Corporation Initiated Coverage of rating Buy with a price target of $26.00
    • On 3/24/2016 Cantor Fitzgerald Reiterated Rating Buy with a price target of $29.00
    • On 8/4/2016 BTIG Research Reiterated Rating Hold with a price target of $14.00
    • On 8/26/2016 Piper Jaffray Companies Reiterated Rating Overweight with a price target of $21.00
    • On 11/2/2016 J P Morgan Chase & Co Downgraded rating Overweight to Neutral with a price target of $25.00 to $16.00
    • On 11/4/2016 Leerink Swann Reiterated Rating Outperform with a price target of $21.00 to $14.00

    Recent Trading Activity for Intersect ENT, Inc. (NASDAQ:XENT)
    Shares of Intersect ENT, Inc. closed the previous trading session at 30.55 up +0.90 3.04% with 368,733 shares trading hands.